Augmented Reality (AR): The Future of "Patient Information Leaflets

June 7, 2021 updated by: NHS Greater Glasgow and Clyde
This project aims to assess a new type of Augmented Reality Patient Information leaflet, in order to demonstrate that it is a beneficial information resource to patients when facing the diagnosis of sarcoma, breast cancer or to explain difficult concepts such as cleft lip repair. There are no published studies on the use of AR in patient leaflets.

Study Overview

Detailed Description

At present, the traditional approach to patient education regarding diseases such as a new cancer diagnosis, is the patient information leaflet. Patient information leaflets often fail to convey the required medical information due to poor levels of literacy in the population, with 20% patients in the UK having the lowest level of adult literacy (equivalent to an individual who is unable to determine how much medicine to give a child from information printed on the package). "Health literacy" - the ability to obtain, understand, act on and communicate health information - is even lower, with estimates that 40% of patients have inadequate levels of health literacy. Additionally, there is a large knowledge gap between what doctors perceive patients understand about an illness, medication, or operation, and what patients actually comprehend and retain during consultation.

The plethora of problems of inadequate information, poor health literacy and patient-doctor knowledge disconnect, may be addressed with an approach to patient information leaflets using a platform that is entirely simulative and visual, thereby overcoming the problem of health literacy. The study builds upon pilot work by this research team on patient leaflets using AR to aid in patient education, visualisation and retention of information (Lo et al 2019).

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Scotland
      • Glasgow, Scotland, United Kingdom, G51 4TF
      • Glasgow, Scotland, United Kingdom, G4 0SF
      • Glasgow, Scotland, United Kingdom, G4 0SF
        • Recruiting
        • Canniesburn Regional Plastic Surgery and Burns Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 90 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients who have undergone reconstructive surgery
  • patients who are awaiting reconstructive surgery
  • patients with sarcoma
  • patients with breast cancer
  • patients with reconstructive flaps
  • patients with or parents of patients with cleft lip and palate
  • Patients with dyslexia will be included

Exclusion Criteria:

  • Cannot speak or read English
  • Blind/severely visually impaired

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Augmented Reality Leaflet
Patient Leaflet with Augmented reality component
The patient leaflet has an Augmented Reality model that appears out of the leaflet when viewed with a smartphone
Active Comparator: Traditional Leaflet
Traditional leaflet without Augmented Reality component
Traditional leaflet with no Augmented Reality capability

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental Effort Rating Scale
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading leaflet)
Validated scale for cognitive load/ ease of understanding leaflet. Single item scale with rating 1 = very, very low mental effort to 9 = very, very high mental effort. Lower score is better
Single point at day 1 (Patient assesses leaflet once after reading leaflet)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Patient Satisfaction
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading leaflet)
Visual analogue scale, overall satisfaction with patient leaflet. Visual analogue scale will be converted to numerical scale 0-100, with higher being better or more satisfied
Single point at day 1 (Patient assesses leaflet once after reading leaflet)
Instructional Motivation Materials Survey
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading leaflet)
Assessment of patient learning motivation after reading leaflet. 36 items, each item rated by Likert scale 1-5. Higher score is better.
Single point at day 1 (Patient assesses leaflet once after reading leaflet)
Usefulness Scale for Patient Information (USE scale)
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading leaflet)
9 item scale with Likert rating 0-10 for each item. Total score out of 90, with 3 sub scales measuring cognitive, emotional and behavioural dimensions. Higher score is better.
Single point at day 1 (Patient assesses leaflet once after reading leaflet)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective interview
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading both leaflets)
Patients will be interviewed regarding opinions of the two types of patient leaflet.
Single point at day 1 (Patient assesses leaflet once after reading both leaflets)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2020

Primary Completion (Anticipated)

December 30, 2021

Study Completion (Anticipated)

March 30, 2022

Study Registration Dates

First Submitted

November 2, 2020

First Submitted That Met QC Criteria

November 2, 2020

First Posted (Actual)

November 6, 2020

Study Record Updates

Last Update Posted (Actual)

June 10, 2021

Last Update Submitted That Met QC Criteria

June 7, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Available on reasonable written request following publication.

IPD Sharing Time Frame

Following publication and for 1 year

IPD Sharing Access Criteria

Available on reasonable written request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcoma

Clinical Trials on Augmented Reality

Subscribe